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Abstract
Background: Evaluation of the possible implications of genomic variants is an increasingly important task in the
current high throughput sequencing era. Structural information however is still not routinely exploited during this
evaluation process. The main reasons can be attributed to the partial structural coverage of the human proteome
and the lack of tools which conveniently convert genomic positions, which are the frequent output of genomic
pipelines, to proteins and structure coordinates.
Results: We present G23D, a tool for conversion of human genomic coordinates to protein coordinates and
protein structures. G23D allows mapping of genomic positions/variants on evolutionary related (and not only
identical) protein three dimensional (3D) structures as well as on theoretical models. By doing so it significantly
extends the space of variants for which structural insight is feasible. To facilitate interpretation of the variant
consequence, pathogenic variants, functional sites and polymorphism sites are displayed on protein sequence and
structure diagrams alongside the input variants. G23D also provides modeling of the mutant structure, analysis of
intra-protein contacts and instant access to functional predictions and predictions of thermo-stability changes.
G23D is available at http://www.sheba-cancer.org.il/G23D.
Conclusions: G23D extends the fraction of variants for which structural analysis is applicable and provides better
and faster accessibility for structural data to biologists and geneticists who routinely work with genomic
information.
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Abbreviations: HTS, High throughput sequencing; PDB, Protein data bank; WES, Whole exome sequencing.
Background
Understanding the consequence of protein-coding point
mutations is crucial to elucidate mechanisms of function
and disease. This need has become even more urgent in
recent years as next generation sequencing technologies
and downstream pipelines typically identify many muta-
tions which should be rapidly and accurately prioritized
to assess their relevance. Most of the recent sequencing
studies specify positions of interest according to the
coordinates of the reference genome. Nevertheless, the
numbering system of proteins in general and protein
structures in particular, is by essence very different from
that of the reference genome. Thus, to bridge the gap
between genomic coordinates and those of proteomics
and structural biology, efficient and convenient conver-
sion tools are needed. To date, evaluation of genomic
variants is mainly based on sequence features and se-
quence conservation scores. Structural data are rarely
applied due to limited structural coverage of the human
proteome and the above mentioned technical obstacles.
However when applicable, structural data can be used to
accurately calculate free energy changes, locate the spatial
position of the residue with respect to known critical posi-
tions in the protein and known intermolecular interfaces.
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This issue is an example of the major challenge we are fa-
cing in the high throughput sequencing (HTS) era, which
is to integrate efficiently and conveniently large amount of
data from distinct origins. The tool presented here, G23D,
enables mapping and visualization of genomic variants on
three dimensional (3D) structures of proteins and helps
integrate genomic data (either user provided or data from
public databases) and protein structural data.
Tools for conversion from genomic coordinates to
structural data already exist, but their functionality is
often limited. MuPit [1] provides an interface to locate
genomic positions onto available predetermined struc-
tures of the exact protein. Polyphen2 [2] and Mutation
Assessor [3] provide structural information, albeit lim-
ited, for lists of variant. Some tools like SNPs3D [4],
MutDB [5], LS-SNP/PDB [6] and Cn3D (http://
www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml) en-
able the user to explore variants which are stored at
variant databases but not to upload new user defined
variants. A number of other cancer related tools, includ-
ing Cancer3D (http://www.cancer3d.org/) and the CBI
portal (http://www.cbioportal.org/) also allow structural
analyses. Tools which are not web-based exist as well [7,
8]. Ball-SNP [8] for example, allows integration of UCSF
chimera with Cytoscape and other resources for integra-
tive visualization of networks, sequences and structures.
These tools enable the use of more sophisticated model-
ling features, but are obviously, less accessible to the
community. There are also other good tools, like ELAP-
SIC [9] and SNPeffect [10] for analysis of functional, sta-
bility and protein-protein interactions changes upon
point mutations which requires protein or structure in-
formation input, and do not support conversions be-
tween genomic and protein coordinates.
The new tool we present here, G23D, further helps to
extend the utilization of structural data in several differ-
ent ways. The structural data which is being scanned in-
cludes also homologous proteins and theoretical models.
The importance of including homologous proteins in
structural analysis has recently been demonstrated, in
particular for analysis of interactions [11, 12]. G23D
retrieves and displays hits from the PDB [13] which are
not only identical but also similar to the input protein
(i. e. homologous), under the well supported assump-
tion that related sequences adopt a similar structural
fold. Moreover, G23D also utilizes theoretical models
from ModBase [14]. Thus, G23D facilitates structural
analyses for a much broader space of proteins. We
aimed to provide flexibility in selecting the appropriate
structure template for a given genomic location.
Therefore, the user can choose the most appropriate
reference structure in each case and has considerable
control over the filtering of the structural hits accord-
ing to criteria such as similarity level with the input
protein and the quality of the structure. G23D provides
convenient and rapid conversion of genomic coordinates
(or protein positions) to structural coordinates. It then al-
lows instant on-line visualization of the structural context
of the input variants, including modeling of the mutated
amino acid and simultaneous visualization of the input
variant alongside known pathogenic and non-pathogenic
variants. Additional structure-based analysis features are
provided as discussed below.
Implementation
The most significant steps in the technical implementa-
tion of the site are the conversions between genomic co-
ordinates and protein sequence coordinates and between
protein sequence coordinates and protein structure co-
ordinates (Fig. 1). G23D employs third party databases
and newly developed offline pre-processing steps to ob-
tain these conversions in advance.
dbNSFP [15] is used to convert genomic coordinates
(GRCh37 or GRCh38 human reference) to uniprot pro-
tein coordinates. dbNSFP is frequently updated and cur-
rently version 3.1 is being used. Protein blast [16] is then
applied for alignment of all Uniprot entries versus the
PDB. The alignment not only retrieves PDB entries of
the relevant proteins, but also detects structures of re-
lated proteins, either orthologs or paralogs, which can
be used for structural analyses of the subject protein to a
certain degree. S2C (http://dunbrack.fccc.edu/Guoli/s2c/)
is applied for conversion of sequence and residue numbers
from the PDB ATOM coordinates record.
The G23D site is mostly implemented in CGI com-
bined with JavaScript and SVG. The 3D visualization is
based on JSmol [17] which is a java-independent tool
supported by all operating systems and major browsers
without the need to install additional software or plu-
gins. The site is composed of three main layers: an input
layer, hits selection layer and an analysis layer. The re-
quested variants are submitted to the input layer. The
structures which cover these coordinates of the variants
are then displayed in the hits layer, where hits can be fil-
tered by various criteria. Selected hits can then be visual-
ized and studied in the analysis layer which includes the
JSmol molecular graphics session and additional struc-
tural information and analyses options. More detailed
description of the various components is provided in the
results section.
G23D employs data from many distinct sources. Proteins
3D structures are extracted from the PDB [13]. Protein the-
oretical models are retrieved from ModBase [14]. Protein
sequences were downloaded from Uniprot [18]. Variants
information was taken from COSMIC [19] and ClinVar
[20]. Single nucleotide polymorphisms (SNPs) were taken
from the common_no_known_medical_impact.vcf file of
ClinVar (variants seen in healthy human population).
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Protein residue conservation scores were taken from
HSSP [21]. Motifs and domains were taken from Prosite
[22]. Protein secondary structures and disordered re-
gions were downloaded from DisProt [23].
As this work describes implementation of software
and does not involve human materials, confidential hu-




G23D is a web-based tool which can be accessed by pro-
viding genomic coordinates, dbSNP id or protein pos-
ition. Alternatively, an official gene symbol or a protein
name can be provided as an input. Following submission
of the requested information in the input page (Fig. 2)
the coordinates are converted to protein space using
Fig. 1 Schematic flowchart of the G23D pipeline and the resources being used. Genomic coordinates are converted to protein coordinates using
dbNSFP. The proteins are then used to retrieve models from ModBase and their sequence is used for a blast search against the PDB. S2C
(Roland Dunbrack lab) is used to convert sequence position to index of coordinates within PDB files. JSmol is used to visualize the hits. Side chain
modeling programs are applied to model the mutant side chain. Comparative contact analyses using contact surface areas and stability analyses
are based on the structure hits. Shaded boxes indicate steps which are pre-processed in advance and not during run-time
Fig. 2 G23D front page includes the forms in which genomic coordinates, protein coordinates, dbSNP id, official gene symbol or protein name
can be supplied. For genomic coordinates we support versions hg19 and hg38 (GRCh37 or GRCh38, respectively) of the human genome
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dbNSFP [15]. A search is then performed to check
which structure entries cover the input site. Sequences
of PDB hits and ModBase hits are aligned to the se-
quence of the protein spanning the input coordinates.
The user can easily explore the exact regions spanned by
the structures and the similarity level to the protein of
interest, as indicated by the color gradients (Fig. 3a).
The same page also contains more detailed 3-way align-
ments of the structure hits (Fig. 3b). The first sequence
is that of the query protein. Several query sequences
may appear in this page as the mutation might be
spanned by several distinct isoforms. The second line
shows the sequence of the protein of the structure hit
(SEQRES information in case of a PDB entry). The third
line shows the part of the protein for which a 3D struc-
ture is available (ATOM part of the PDB entry). Missing
domains, disordered regions and other undetermined re-
gions will therefore not appear in this line. The amino-
acid position affected by the input mutation (if provided)
is highlighted. A link to the JSmol visualization page fol-
lows the alignment.
The selected structure hits are displayed in a JSmol
session (Fig. 4). The 3D display is shown in the center
(Fig. 4a) in cartoon representation. The input variant, if
indicated in the input page and included in the struc-
ture, appears in black. Database variants (if present) ap-
pear in the same color scheme of the sequence
alignment and are shown in stick representation. The
structural context of the input variant can therefore be
evaluated with respect to known variants. Currently,
G23D displays data from dbSNP [24], ClinVar [20], Cos-
mic variants [19] as well as catalytic residues from Cata-
lytic Site Atlas [25]. Interactive sequence alignment,
similar to that found in the hits’ page, is located in the
bottom of the page (Fig. 4b). Residues selected in the se-
quence panel are highlighted on the structure. This
panel includes also information regarding conservation,
secondary structure and disorder regions, if available.
Prosite [22] motifs are also shown in the sequence panel
and are mapped to the structure. The Control panel
(Fig. 4c) allows manipulation of the structure sessions
(many more control options are available in the JSmol
menu). The control panel also contains links to the con-
tact analyses and stability predictions.
Using the combined sequence-structure presentation,
the user can easily explore the structural context of se-
lected sequence locations and patterns. The sequence
conservation values from HSSP [21] can also be dis-
played on both the sequence and the structure using
conservation color scale.
Side chain modeling and contact analysis
G23D is not solely a visualization tool, as it provides
additional modeling and analyses features which gener-
ally cannot be found in equivalent tools. The amino acid
in the mutated position is modeled using SCcomp [26]
Fig. 3 The hits’ page displays schematic and detailed alignments of the structural hits identified with the input protein (or the proteins) spanning
the input genomic coordinates. a Schematic display of the alignment and the spanned regions. Horizontal colored bars, presented in a manner
similar to Blast’s results page, serve as links to the detailed alignments located later in the page. The green bar indicates the query protein; red
bars indicate PDB hits; while blue bars indicate ModBase models of the query proteins. Several isoforms might be found for the input protein. b
Detailed alignments of the query protein (upper sequence line) and structure hits. Two sequence lines appear for the structure hit. One shows the
protein sequence (PDB SEQRES record) and the second shows the sequence of the resolved coordinates (PDB ATOM record). In the first two
alignments in this example (Q61 in NRAS) the loop which contains the variant is missing while in the third it is present. Description of the
structure hits and indications for the alignment quality precede the alignment display. Residues which appear in dbSNP, Cosmic and Clinvar
databases are indicated by various colors on the query sequence. The input variant is indicated by green arrows below and above the
alignments. A link to the JSmol structure visualization page follows the alignment
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or Scwrl [27]. Both programs are quite accurate but it
should be stressed that both methods model side chains
on a fixed backbone, so if backbone conformational
changes are involved the model may not be accurate.
Therefore caution is needed when the mutant side chain
is larger than the wild type side chain in the protein
core. In the 3D interactive session the user can explore
the side chain conformation of the mutant, instead or
alongside the wild type residue (Fig. 5a).
Given the structure of the wild-type protein and the
mutation position, the user can explore the molecular
contacts in which the residue participates. Contact sur-
face areas and solvent accessible surface areas are cal-
culated using analytic procedure, as described in
Mcconkey et al. [28, 29], which applies Voronoi tessel-
lation to allocate contact surfaces between neighboring
atoms. The remaining surface of each atom, not
assigned to contact with other atoms, is the solvent ac-
cessible surface (Fig. 5b).
The user obtains a table (Fig. 5c) which summarizes
the data at the residue level. Each line in the table pro-
vides information on a single residue which forms con-
tact/s with the residue coded by the input variant. These
contacting residues are colored according to the same
coloring schemes of G23D to help the user assess their
significance. The information in the table includes the
contact surface area (Å2) and the minimal atomic dis-
tance (Å) between any two atoms of the two residues.
The user can further explore atomic contacts of contact-
ing residues. Pressing the residue number in the left col-
umn of the table opens a new table, which provides
atomic level information regarding interactions between
atoms of the mutated residue and atoms of the interact-
ing residue (Fig. 5d), including inter atomic contact sur-
face area and inter atomic distance. Altogether, the user
can evaluate the effect of the mutation by comparing the
contacts and solvent accessible surface area of both the
wild type residue and the mutant residue. The user can
also manually examine the possible effect of the muta-
tions over the 3D molecular graphics session.
G23D also provides links to third party programs
which predict the consequences of the mutation by vari-
ous considerations. If the variant is supplied by its gen-
omic coordinates, then a link to the data of the relevant
entry in dbNSFP [15] is provided. This database holds
pre-compiled predictions for each protein coding variant
Fig. 4 The structure visualization page is divided to three panels. a The protein is shown in cartoon representation, and the input variant
(light green) and database variants (red, yellow and green with the same color scheme of the sequence alignment) are shown in stick representation.
The sequence alignment b is similar to that found in the hits’ page. Additional layers of information such as conservation, secondary structure and
disorder may follow the sequences. Residues on the sequence can be marked on the structure diagram. The Control panel c provides easy access to
some common graphical features, alternate visualization of the wild-type and the mutant structures and links to contact analyses and
stability predictions
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in the genome regarding the possible functional signifi-
cance of the variant. Predictions are available for eight
different popular programs including SIFT, polyphen2,
LRT, MutationTaster, MutationAssessor, FATHMM and
PROVEAN. Evolutionary conservation is the most im-
portant individual feature in these predictions which
generally do not consider structural features. Consensus
predictions (i.e. meta predictions) are also provided and
are in principal more accurate than the individual pre-
dictors [30].
In case structural information is available, G23D pro-
vides links to two different programs for thermostablity
predictions, FoldX [31] and I-Mutant-2.0 [32]. The predic-
tions of these tools are available from the 3D session page.
The DNA methyltransferase 3B (DNMT3B) case study
DNMT3B is a gene responsible for de novo cytosine-5-
methyltranferase (m5C) in the human genome. Familial
mutations in this gene were reported to be the cause of
autosomal recessive Immunodeficiency Centromeric in-
stability and facial anomalies (ICF) syndrome [33]. Fig. 6
demonstrates how G23D can assist in meaningful struc-
tural analysis of a variant in this gene. This example will
serve as an illustrative case study as well as a short tutorial
for the utility of G23D.
A patient at two years of age was admitted to our hos-
pital due to severe failure to thrive (FTT), immunodefi-
ciency and diarrhea. She was the first born child of
consanguineous parents from a Palestinian descent. In
order to determine the genetic cause for her syndrome
we performed whole exome sequencing (WES) of DNA
extracted from her peripheral blood. The analysis re-
vealed a strong candidate variant in chromosome 20,
position 31387128 (hg19) from G to A, lying inside the
genomic region of DNMT3B (c.1753G > A). Providing
the genomic coordinates in the input page of G23D, in-
stantly revealed that there are no PDB structure of
DNMT3B. There are, however, several structures of the
closely related DNMT3A (70 % identity in the catalytic
domain) which cover the C-terminal part of the protein
(Fig. 6a). The input variant resides in the catalytic do-
main located in the C-terminal part. There are also sev-
eral homology models of the DNMT3B catalytic domain
in ModBase. According to isoform Q9UBC3, the amino
acid position affected by the change is Ala585 and the
substituted amino acid is Thr (codon GCG to ACG).
Note that if genomic position is provided, the protein
position might differ for other isoforms.
By selecting the PDB hit bar of PDB file 4u7p [34], a
detailed alignment between the query protein and the
Fig. 5 Modeling and stability prediction features in G23D. a A G23D model displaying the mutant structure instead, or together with, the wild
type. The modeling is done using Sccomp, a side chain prediction program. b Contact surface areas between atoms and solvent accessible
surfaces are analytically calculated using Voronoi tessellation. This procedure allocates the surface area of each atom to its neighbors (colored arcs)
and the solvent (dashed arc). c A residue-level summary table lists all contacts and minimal distance to contacting residues for both wild type
and mutant structures. Database residues are colored according to the general coloring of G23D. d By pressing on a residue in the left column of
the residue-level table, the user can explore all atomic level interactions between the input variant and the chosen residue
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sequence in the PDB file (of DNMT3A) is presented.
Position 585 is coded by nucleotides which appear to
overlap cancer variants in Cosmic, as indicated by the
yellow background. In fact, this position is also known
to be an HGMD [35] variant, suggesting clinical import-
ance. Several additional residues in the close vicinity are
reported in cosmic and ClinVar databases. By clicking
on the JSmol link, a 3D session appears, showing the
structure (Fig. 6b). The input position 585 is depicted in
black and the database variants are depicted in colors
according to the G23D scheme. The structure of the
threonine mutation residue can be seen in the 3D ses-
sion by checking the “mut” button in the control panel.
The list of contacts, available by a button click from the
3D session (Fig. 6c) reveals clashes with two adjacent
residues (marked by arrows). Such clashes suggest signifi-
cantly decreased stability of the mutant and/or changes
in the local backbone conformation. Indeed prediction
of I-Mutant2.0, directly accessed from the structural
session, suggests a decreased stability of the mutant
(Fig. 6d). Interestingly, the variant reported by Wijmenga
et al. [36] in the same protein position also includes a lar-
ger mutated side chain (Val). Val has a similar shape like
Thr, and is also expected to give rise to changes in the
backbone conformation.
Moreover, many known clinical relevant variants are lo-
cated in close proximity to position 585. The quantitative
contact analysis (Fig. 6c), indeed suggests that position
585 (which appears as position 644 in the ATOM records
of PDB 4u7p) has direct contact with other known patho-
genic variants such as the residue 622 (681 in the PDB
ATOM records). The region which spans position 585 is
highly conserved as indicated by the “9” scores in the
HSSP conservation profile (Fig. 6e). The sequence profile
indicates that this region is part of a known motif of meth-
yltransferases (SAM_MT_C5; Prosite ID: PS51679).
Fig. 6 Example of G23D variant analysis in the catalytic domain of methyl-transferase (DNMT3B). Variants in this protein and specifically in position
A585 are known to be related to the ICF syndrome. a DNMT3B has no resolved structures in the PDB, but by using G23D the user can rapidly
detect structures of the close homolog DNMT3A (red) and several theoretical models which span the variant (blue). The color gradient indicates
the sequence similarity to the PDB protein or to the template protein used for the homology modeling. b Analysis based on the structure of the
catalytic domain of DNMT3A which shares 70 % identity with DNMT3B, suggests that the residue in position 585 (shown in black) is completely
buried in the protein core and is located on the interface between a helix and a loop. It is positioned close to known pathogenic residues in both
ClinVar (red colors) which are automatically being displayed in G23D and HGMD (here manually added in purple). Many other positions appear in
Cosmic (yellow). The methyl donor (SAH), whose binding pocket is likely affected by mutations in position 585, appears in magenta. c From the
sequence diagram, located in the bottom of the JSmol structure session it can be deduced that the region is very conserved (conservation score
of 9) and that it is part of the known Prosite methyltransferase motif (PS51679; in pink). d Contact analysis shows that position 585 has direct
contact with some of the known disease related positions shown in panel B, and that the minimal distance of the mutated residue causes steric
clashes with two neighbors (marked in arrows). e Stability analysis of the A585T variant (equivalent to position 644 in PDB 4u7p ATOM section)
using I-Mutant-2, directly accessed from G23D, suggests decreased stability of the mutant structure
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There is a consensus among eight different function
prediction tools which are included in the dbNSFP
database [15] that A585T is a deleterious change, as can
be deduced by a link located in the upper part of the
G23D hits’ page. DNMT3B variants described in the
literature seem to disrupt the function of the enzyme by
several distinct mechanisms, including changing protein
stability, altering DNA binding affinity, affecting
oligomerization with other methyltransferase family
members and affecting binding affinity of the SAH me-
thyl donor cofactor [37]. The variants in position 585
appear to belong to the last group. Ala 585 is located
close to the SAH but does not directly contact it. Its
side chain points to the opposite direction of the cofac-
tor (shown in magenta in Fig. 6a) and is completely
buried (Fig. 6c). Upon mutation, backbone changes are
inevitable in order to accommodate the larger side
chain. These changes are likely to affect the conform-
ation of the nearby loop which directly interacts with
the cofactor.
Conclusions
Structural configuration is the basis for understanding
molecular stability of molecules and interactions be-
tween molecules. It is also fundamental for understand-
ing the molecular mechanisms which drive certain
variants to be pathogenic. Due to the limited availability
of structural data and technical difficulties in usage,
structural information is often overlooked during func-
tional interpretation of variants.
We believe that G23D will help to narrow this gap,
and will allow more researchers to include protein
structural aspects in their studies of human variants.
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